West Pharmaceutical Services WST Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $138.8M+54.6% | $132.1M+1.5% | $140M+2.9% | $131.8M+18.4% | $89.8M-22.1% | ||
| $44.6M+14.1% | $46.4M+16.6% | $42.3M+7.6% | $40.8M+7.4% | $39.1M+12.7% | ||
| $6.6M+408% | $6.7M+55.8% | $8.4M+64.7% | $7.4M+72.1% | $1.3M-74.0% | ||
| $300K0.0% | $7.3M+35.2% | $300K-70.0% | $3.8M+1,167% | $300K-50.0% | ||
| —— | -$1.73M-112% | -$1.73M-112% | -$1.73M-112% | -$1.73M-112% | ||
| —— | $15.7M+250% | $15.7M+250% | $15.7M+250% | $15.7M+250% | ||
| —— | $4.48M+517% | $4.48M+517% | $4.48M+517% | $4.48M+517% | ||
| -$1M-134% | -$112.5M-248% | -$2.5M-219% | $4M+115% | $2.9M-91.6% | ||
| —— | -$2.43M-267% | -$2.43M-267% | -$2.43M-267% | -$2.43M-267% | ||
| —— | $2.63M-21.6% | $2.63M-21.6% | $2.63M-21.6% | $2.63M-21.6% | ||
| $89.9M-30.5% | $251.1M+32.1% | $197.2M+9.5% | $177.1M+7.3% | $129.4M+9.5% | ||
| $42.7M-40.1% | $76.1M-27.5% | $63.3M-22.1% | $75.2M-25.0% | $71.3M-21.3% | ||
| -$42.7M+40.1% | -$76.1M+27.4% | -$63.3M+22.9% | -$75.2M+25.7% | -$71.3M+21.3% | ||
| $15.8M+3.9% | $15.8M+3.3% | $15.1M+4.1% | $15.1M+3.4% | $15.2M+3.4% | ||
| $297.6M+123% | —— | —— | $500K-99.7% | $133.5M-50.0% | ||
| $5.5M+120% | $3.1M+107% | $2.2M-46.3% | $3.5M-31.4% | $2.5M-83.1% | ||
| $300K+50.0% | $300K+200% | $300K0.0% | $300K-98.7% | $200K+100% | ||
| $2.5M0.0% | $200K0.0% | $100K— | $0-100% | $2.5M-53.7% | ||
| -$308.7M-110% | -$11.7M+83.0% | -$11.5M+82.1% | -$14.9M+93.2% | -$147M+45.8% | ||
| -$8.4M-199% | —— | —— | $18.5M+1,782% | $8.5M+198% | ||
| -$269.9M-236% | $162.8M+2,684% | $118.8M— | $105.5M+168% | -$80.4M+68.1% | ||
| —— | $75K-40.0% | $75K-40.0% | $75K-40.0% | $75K-40.0% | ||
| —— | $31.3M+75.4% | $31.3M+75.4% | $31.3M+75.4% | $31.3M+75.4% | ||
| $600K-33.3% | $600K-33.3% | $700K-22.2% | $600K-33.3% | $900K0.0% | ||
| $300K0.0% | $7.3M+35.2% | $300K-70.0% | $3.8M+1,167% | $300K-50.0% | ||
| $44.6M+14.1% | $46.4M+16.6% | $42.3M+7.6% | $40.8M+7.4% | $39.1M+12.7% | ||
| —— | $2.63M-21.6% | $2.63M-21.6% | $2.63M-21.6% | $2.63M-21.6% | ||
| $102.9M+103,000% | —— | —— | $4.1M— | -$100K-100% | ||
| —— | -$2.43M-267% | -$2.43M-267% | -$2.43M-267% | -$2.43M-267% | ||
| -$1M-134% | $3M— | —— | $4M+2.6% | $2.9M-21.6% | ||
| —— | $150K+130% | $150K+130% | $150K+130% | $150K+130% | ||
| $300K+50.0% | $300K+200% | $300K0.0% | $300K-98.7% | $200K+100% | ||
| $2M+5.3% | $1.5M-6.3% | $1.8M-5.3% | $1.7M0.0% | $1.9M-5.0% | ||
| $900K+12.5% | —— | $900K— | $800K— | $800K— | ||
| —— | $31.3M+75.4% | $31.3M+75.4% | $31.3M+75.4% | $31.3M+75.4% | ||
| $47.2M-18.8% | $175M+105% | $133.9M+35.5% | $101.9M+57.3% | $58.1M+111% | ||
| $47.2M-18.8% | $175M+105% | $133.9M+35.5% | $101.9M+57.3% | $58.1M+111% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does West Pharmaceutical Services generate?
- West Pharmaceutical Services (WST) generated $715.3M in operating cash flow over the trailing twelve months.
- What is West Pharmaceutical Services's free cash flow?
- After $257.3M of capital expenditures, West Pharmaceutical Services's free cash flow was $458.0M over the trailing twelve months, up 49.2% year over year.
- Where does West Pharmaceutical Services's cash flow data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
